These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 30372431)
1. Beyond financial conflicts of interest: Institutional oversight of faculty consulting agreements at schools of medicine and public health. Mello MM; Murtagh L; Joffe S; Taylor PL; Greenberg Y; Campbell EG PLoS One; 2018; 13(10):e0203179. PubMed ID: 30372431 [TBL] [Abstract][Full Text] [Related]
2. Institutional Oversight of Faculty-Industry Consulting Relationships in U.S. Medical Schools: A Delphi Study. Morain SR; Joffe S; Campbell EG; Mello MM J Law Med Ethics; 2015; 43(2):383-96. PubMed ID: 26242961 [TBL] [Abstract][Full Text] [Related]
3. Researchers' views of the acceptability of restrictive provisions in clinical trial agreements with industry sponsors. Mello MM; Clarridge BR; Studdert DM Account Res; 2005; 12(3):163-91. PubMed ID: 16634168 [TBL] [Abstract][Full Text] [Related]
4. Conflict-of-interest policies for investigators in clinical trials. Lo B; Wolf LE; Berkeley A N Engl J Med; 2000 Nov; 343(22):1616-20. PubMed ID: 11096170 [TBL] [Abstract][Full Text] [Related]
5. The New Academic Environment and Faculty Misconduct. Binder R; Friedli A; Fuentes-Afflick E Acad Med; 2016 Feb; 91(2):175-9. PubMed ID: 26488567 [TBL] [Abstract][Full Text] [Related]
6. Academic medical centers' standards for clinical-trial agreements with industry. Mello MM; Clarridge BR; Studdert DM N Engl J Med; 2005 May; 352(21):2202-10. PubMed ID: 15917385 [TBL] [Abstract][Full Text] [Related]
7. Assessing faculty financial relationships with industry: A case study. Boyd EA; Bero LA JAMA; 2000 Nov; 284(17):2209-14. PubMed ID: 11056592 [TBL] [Abstract][Full Text] [Related]
8. Policies on faculty conflicts of interest at US universities. Cho MK; Shohara R; Schissel A; Rennie D JAMA; 2000 Nov; 284(17):2203-8. PubMed ID: 11056591 [TBL] [Abstract][Full Text] [Related]
9. Judging public health research: epistemology, public health and the law. Wynia MK Am J Bioeth; 2005; 5(6):4-7. PubMed ID: 16282101 [No Abstract] [Full Text] [Related]
10. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. Schulman KA; Seils DM; Timbie JW; Sugarman J; Dame LA; Weinfurt KP; Mark DB; Califf RM N Engl J Med; 2002 Oct; 347(17):1335-41. PubMed ID: 12397192 [TBL] [Abstract][Full Text] [Related]
11. American Society of Clinical Oncology policy statement: oversight of clinical research. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281 [TBL] [Abstract][Full Text] [Related]
12. Sponsored research agreements, university and government licensing, and clinical trial agreements: special contractual and intellectual property rights considerations. Somers JP J Biolaw Bus; 2003; 6(4):5-13. PubMed ID: 15072054 [TBL] [Abstract][Full Text] [Related]
13. Responses of medical schools to institutional conflicts of interest. Ehringhaus SH; Weissman JS; Sears JL; Goold SD; Feibelmann S; Campbell EG JAMA; 2008 Feb; 299(6):665-71. PubMed ID: 18270355 [TBL] [Abstract][Full Text] [Related]
14. Looking a gift horse in the mouth: corporate gifts supporting life sciences research. Campbell EG; Louis KS; Blumenthal D JAMA; 1998 Apr; 279(13):995-9. PubMed ID: 9533497 [TBL] [Abstract][Full Text] [Related]
15. Tenure in transition: trends in basic science faculty appointment policies at U.S. medical schools. Liu M; Mallon WT Acad Med; 2004 Mar; 79(3):205-13. PubMed ID: 14985192 [TBL] [Abstract][Full Text] [Related]
17. Conflict of Interest Policies at French Medical Schools: Starting from the Bottom. Scheffer P; Guy-Coichard C; Outh-Gauer D; Calet-Froissart Z; Boursier M; Mintzes B; Borde JS PLoS One; 2017; 12(1):e0168258. PubMed ID: 28068362 [TBL] [Abstract][Full Text] [Related]
18. NIH conflicts rules are not right for universities. Korn D; Ehringhaus SH Nature; 2005 Apr; 434(7035):821. PubMed ID: 15829935 [No Abstract] [Full Text] [Related]
19. CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances. Newsome SD; Aliotta PJ; Bainbridge J; Bennett SE; Cutter G; Fenton K; Lublin F; Northrop D; Rintell D; Walker BD; Weigel M; Zackowski K; Jones DE Int J MS Care; 2016; 18(6):314-323. PubMed ID: 27999526 [TBL] [Abstract][Full Text] [Related]
20. Fulfilling the social contract between medical schools and the public. McCurdy L; Goode LD; Inui TS; Daugherty RM; Wilson DE; Wallace AG; Weinstein BM; Copeland EM Acad Med; 1997 Dec; 72(12):1063-70. PubMed ID: 9435712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]